Myovant Historical Income Statement

MYOV -  USA Stock  

USD 20.28  0.22  1.07%

Historical analysis of Myovant Sciences income statement accounts such as Operating Expenses of 289.6 M can show how well Myovant Sciences performed in making a profits. Evaluating Myovant Sciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Myovant Sciences's future profits or losses. Financial Statement Analysis is much more than just reviewing and examining Myovant Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Myovant Sciences is a good buy for the upcoming year.
Additionally, see Stocks Correlation.

Search Historical Statements 

 
Refresh

Myovant Sciences Net Income

(275.28 Million)Share

About Myovant Income Statement Analysis

Myovant Sciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Myovant Sciences shareholders. The income statement also shows Myovant investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Myovant Sciences Income Statement Chart

Myovant Sciences Income Statement is one of the three primary financial statements used for reporting Myovant's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Myovant Sciences revenue and expense. Myovant Sciences Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Myovant Sciences Research and Development Expense is fairly stable at the moment as compared to the past year. Myovant Sciences reported Research and Development Expense of 136.71 Million in 2020. Selling General and Administrative Expense is likely to climb to about 195.7 M in 2021, whereas Earning Before Interest and Taxes EBIT is likely to drop (263.7 M) in 2021.

Earning Before Interest and Taxes EBIT

Earnings Before Interest and Tax is calculated by adding Income Tax Expense and Interest Expense back to Net Income.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Myovant Sciences financial statement analysis. It represents the amount of money remaining after all of Myovant Sciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Revenues

Revenues refers to the total amount of money received by Myovant Sciences for goods sold or services provided during a certain time period. It also includes all of Myovant Sciences sales as well as any other increase in Myovant Sciences equity.Revenues are reported on Myovant Sciences income statement and calculated before any expenses are subtracted. Amount of Revenue recognized from goods sold; services rendered; insurance premiums; or other activities that constitute an earning process. Interest income for financial institutions is reported net of interest expense and provision for credit losses.
Most accounts from Myovant Sciences income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Myovant Sciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Additionally, see Stocks Correlation.Myovant Sciences Research and Development Expense is fairly stable at the moment as compared to the past year. Myovant Sciences reported Research and Development Expense of 136.71 Million in 2020. Selling General and Administrative Expense is likely to climb to about 195.7 M in 2021, whereas Earning Before Interest and Taxes EBIT is likely to drop (263.7 M) in 2021.
 2020 2021 (projected)
Interest Expense10.4 M10.39 M
Gross Profit53.11 M52.8 M

Myovant Sciences income statement Correlations

Myovant Sciences Account Relationship Matchups

Myovant Sciences Investors Sentiment

The influence of Myovant Sciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Myovant. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - MYOV

Myovant Sciences Investor Sentiment

Most of Macroaxis users are now bullish on Myovant Sciences. What is your trading attitude regarding investing in Myovant Sciences? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Myovant Sciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Stocks Correlation. Note that the Myovant Sciences information on this page should be used as a complementary analysis to other Myovant Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Myovant Stock analysis

When running Myovant Sciences price analysis, check to measure Myovant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Myovant Sciences is operating at the current time. Most of Myovant Sciences' value examination focuses on studying past and present price action to predict the probability of Myovant Sciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Myovant Sciences' price. Additionally, you may evaluate how the addition of Myovant Sciences to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
The market value of Myovant Sciences is measured differently than its book value, which is the value of Myovant that is recorded on the company's balance sheet. Investors also form their own opinion of Myovant Sciences' value that differs from its market value or its book value, called intrinsic value, which is Myovant Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myovant Sciences' market value can be influenced by many factors that don't directly affect Myovant Sciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myovant Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Myovant Sciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myovant Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.